We Dislike LLM Output, not Because of Comprehension (中文)
2026-11-08
While LLMs till now still possess significantly different observable (as in functionalism) output patterns from humans,
do note that (I) Humans slop and hallucinate from time to time. We have seen countless
shitshows emitted by our dearest co-workers; (II) As in the last paragraph of my linked post, "One can definitely argue that 'theoretically LLMs can do whichever thing human is doing'".
This is, of course, debatable but hard and non-trivial, but we cannot deny that LLMs are already
showing superhuman behaviors and excel in various (honestly mainly math) fields. But there is
still more to argue for why we should not just hand everything over to LLMs.
We usually argue that we should limit or intervene in the use of LLMs because we need human comprehension.
But comprehension itself is already quite troublesome. The Chinese Room Argument [1]
was intended to fight strong functionalism and computationalism, yet it in turn bites itself
by arguing on top of the dubious Cartesian assumption: that genuine "understanding" consists in
an isolated internal mental state possessing intrinsic intentionality. Wittgenstein's rule-following and Private Language
Argument aimed directly at this (and broader Methodological / Semantic Solipsism) [2]. As synthesized
by SEP (Sec. 1) [3]: The conclusion is that a language in principle unintelligible to anyone but its originating user is impossible. The reason for this is that such a so-called language would, necessarily, be unintelligible to its supposed originator too, for he would be unable to establish meanings for its putative signs.
The problem does not lie in comprehension. It lies in normativity. Note that when we argue, we say
"we should not hand everything over to LLMs". Regardless of the PLA, even if we indeed
have measurable neurobiological states, or "Qualia", etc., they are normatively inert facts.
The Chinese Room mistakes a factual assertion of understanding/comprehension for a normative
standing. In isolation, neither a biological brain nor a self-attention block possesses semantic normativity [4].
But in reality, we do have normative objects, e.g. legal contracts, a program emitting right
or wrong results. By normative pragmatism [5], the normativity is gained from
external social structures and communal practices - when we say someone "understands" a concept, it is not some pure
private mental process, but a social standing: undertaking commitments and liabilities in the game of giving and asking for reasons.
Reframing understanding as normative accountability reveals why we feel unsettled about
the Chinese Room scenario again - and why human slop differs from AI slop. Humans are also black boxes to one another,
yet they are bound by social structures and existential stakes (skin in the game). Because artificial tools lack
such stakes, they can't function as full-fledged normative agents [6];
instead, their integration into society relies on their status as auditable instruments whose
human operators bear the responsibility. But in modern deep learning, this auditability dissolves into massive
pretraining on whatever giant corpora AI companies can acquire, and into mysteriously interacting weights:
it is epistemic opacity, that is, the cognitive impossibility for human agents to inspect,
decompose, or trace the warrant-generating elements of a computational process [7].
Worth noting that overcoming epistemic opacity is not equivalent to the Cartesian myth of seeking
"intrinsic semantics" (and thus falling back into PLA), but rather a pragmatic intelligibility: the public ability
to grasp counterfactual dependencies, diagnose errors, and intervene [8].
In which case, compared to traditional tools, humanity faces a normative disempowerment: we
cannot hold the system accountable as a peer, nor can we audit and revise it as a tool, to the
extent accountability demands [9].
Additionally, consider pharmacology, in which one might argue that medicine has long relied on
empirically effective drugs. Pharmacology actually faces the same dilemma as in LLM use.
A lot of medicine, while not fully understood end-to-end, is still made partially mechanistically
decomposable (e.g., AstraZeneca turns to the 5R Framework [10]),
on top of which strict clinical regulation and institutional liability shift the skin in the game onto the pharmaceutical companies and prescribing doctors.
Since we cannot give weights genuine existential stakes (or can we? It would be more troublesome if we actually can),
I really hope MechInterp can bring LLMs to a somewhat similar place as pharmacology. It would be a nice pragmatic middle ground.References
- J. R. Searle, “Minds, brains, and programs,” Behav. Brain Sci., vol. 3, no. 3, pp. 417–424, Sep. 1980, doi: 10.1017/S0140525X00005756.
- L. Wittgenstein, Philosophical Investigations, G. E. M. Anscombe, Trans. Oxford, UK: Basil Blackwell, 1953.
- S. Candlish and G. Wrisley, “Private language,” in The Stanford Encyclopedia of Philosophy, Fall 2019 ed., E. N. Zalta, Ed. Stanford, CA, USA: Metaphysics Research Lab, Stanford Univ., 2019. Accessed: Nov. 9, 2026. [Online]. Available: https://plato.stanford.edu/archives/fall2019/entries/private-language/
- W. Sellars, “Empiricism and the philosophy of mind,” in Minnesota Studies in the Philosophy of Science, vol. 1, H. Feigl and M. Scriven, Eds. Minneapolis, MN, USA: Univ. Minnesota Press, 1956, pp. 253–329.
- R. B. Brandom, Making It Explicit: Reasoning, Representing, and Discursive Commitment. Cambridge, MA, USA: Harvard Univ. Press, 1994.
- J. Haugeland, Having Thought: Essays in the Metaphysics of Mind. Cambridge, MA, USA: Harvard Univ. Press, 1998.
- P. Humphreys, “The philosophical novelty of computer simulation methods,” Synthese, vol. 169, no. 3, pp. 615–626, Aug. 2009, doi: 10.1007/s11229-008-9435-2.
- H. W. de Regt, Understanding Scientific Understanding. Oxford, UK: Oxford Univ. Press, 2017.
- A. Matthias, “The responsibility gap: Ascribing responsibility for the actions of learning automata,” Ethics Inf. Technol., vol. 6, no. 3, pp. 175–183, Sep. 2004, doi: 10.1007/s10676-004-3422-1.
- P. Morgan et al., “Impact of a five-dimensional framework on R&D productivity at AstraZeneca,” Nat. Rev. Drug Discov., vol. 17, no. 3, pp. 167–181, Mar. 2018, doi: 10.1038/nrd.2017.244.